Trailing-twelve-month (TTM) revenue is $5.46 Billion with a year-over-year growth of +6.86%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,360,109,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-24 |
| Q4 FY2025Period ended 2025-12-31 | $1,364,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-09 |
| Q1 FY2026Period ended 2026-03-31 | $1,351,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-24 |
| Q2 FY2026Period ended 2026-06-30 | $1,387,035,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-24 |
| TTM revenue | $5,463,344,000 |
Current P/S: $5,060,040,000 market capitalization ÷ $5,463,344,000 TTM revenue = 0.93x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:05:24.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.39B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:09:38.977Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| E&S Lines | $239M | $280M | $334M | $391M | $504M | $606M |
| Insurance Operations | N/A | N/A | N/A |
$5.46B
$5.46 Billion
+6.86%
vs. $5.11B a year ago (TTM)
+11.16%
5 Year compound annual growth rate
1 Year
+6.86%
3 Year
+12.01%
5 Year
+11.16%
10 Year
+9.49%
15 Year
+8.59%
20 Year
+5.88%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $5.34B | +$475.45M | +9.78% |
| 2024 | $4.86B | +$629.17M | +14.87% |
| 2023 | $4.23B | +$674.10M | +18.95% |
| 2022 | $3.56B | +$179.01M | +5.30% |
| 2021 | $3.38B | +$456.89M | +15.63% |
| 2020 |
TTM Growth
+6.86%
3-Year CAGR
+12.01%
5-Year CAGR
+11.16%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| $4.8B |
| Investment Segment | N/A | N/A | N/A | N/A | $454M | $539M |
|---|
| Investments SIGI | $0 | $0 | $0 | $0 | N/A | N/A |
|---|
| Standard Commercial Lines | $2.1B | $2.4B | $2.7B | $3.1B | $3.5B | $3.8B |
|---|
| Standard Personal Lines | $299M | $294M | $299M | $367M | $427M | $408M |
|---|
| Total Insurance Operations | N/A | N/A | N/A | N/A | $4.4B | N/A |
|---|
| $2.92B |
| +$75.78M |
| +2.66% |
| 2019 | $2.85B | +$260.41M | +10.07% |
| 2018 | $2.59B | +$116.10M | +4.70% |
| 2017 | $2.47B | +$185.71M | +8.13% |
| 2016 | $2.28B | +$152.42M | +7.15% |
